• Optimized iPSC Platelet Differentiation: Protocol Innovation

  2026-06-13

  This study presents an optimized protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs), significantly improving yield, reducing time, and cutting costs compared to conventional approaches. By integrating higher initial embryoid body cell counts, medium refinements, and strategic use of small molecules, the protocol advances scalable platelet production for research and therapeutic applications.

• BMS-777607: Precision c-Met Inhibitor for Platelet & Cancer

  2026-06-12

  BMS-777607 stands out as a potent, selective c-Met inhibitor that bridges advanced cancer metastasis models with innovative hiPSC-derived platelet protocols. This guide translates bench data and reference breakthroughs into actionable workflows, troubleshooting insights, and strategic advantages for researchers targeting MET signaling.

• G007-LK Tankyrase 1/2 Inhibitor: Precision Tools for Wnt and

  2026-06-12

  G007-LK unlocks advanced modulation of the Wnt/β-catenin and Hippo/YAP pathways in APC mutation colorectal and hepatocellular carcinoma research, offering unmatched selectivity and cellular activity. With robust in vitro and in vivo efficacy, this APExBIO reagent enables researchers to dissect tumor signaling with quantitative confidence.

• SARS-CoV-2 N Protein Suppresses GADD34-Mediated Innate Immun

  2026-06-11

  This study reveals how the SARS-CoV-2 nucleocapsid protein impairs host innate immunity by sequestering GADD34 mRNA into atypical stress granule-like foci, thus inhibiting interferon production. These findings deepen understanding of viral immune evasion and highlight mechanistic targets for antiviral research.

• MALAT1 Modulates PCT Expression via miR-125b/STAT3 in Sepsis

  2026-06-11

  This study uncovers how the long non-coding RNA MALAT1 regulates procalcitonin (PCT) levels in sepsis through a miR-125b/STAT3-dependent mechanism. The research clarifies a molecular axis critical to sepsis biomarker regulation, offering new insight for diagnostic and therapeutic strategies.

• Bile Acid Retention Disrupts Antigen Presentation in MASH-HC

  2026-06-10

  This study uncovers a mechanistic link between bile acid retention and impaired antigen presentation in metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma (MASH-HCC). The findings demonstrate that targeting bile acid metabolism can restore tumor immunogenicity and enhance response to immune checkpoint blockade, offering new directions for immunotherapy-resistant liver cancer.

• ECL Chemiluminescent Substrate Detection Kit: Sensitivity &

  2026-06-10

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) offers low picogram sensitivity for immunoblotting via horseradish peroxidase (HRP) chemiluminescence. Its extended signal duration and low background are optimized for detection of low-abundance proteins on nitrocellulose or PVDF membranes. The kit enables robust, reproducible protein detection and streamlined workflows for research applications.

• Pemetrexed in Translational Oncology: Mechanisms, Models, an

  2026-06-09

  This article explores how pemetrexed, a multi-targeted antifolate, is reshaping translational cancer research. By integrating mechanistic insights, gene expression profiling, and practical workflow guidance, it provides strategic recommendations for researchers tackling drug resistance and DNA repair vulnerabilities in malignant mesothelioma and beyond.

• Clasto-Lactacystin β-lactone: Precision Proteasome Inhibitor

  2026-06-09

  Clasto-Lactacystin β-lactone empowers researchers with potent, irreversible proteasome inhibition for dissecting protein degradation in advanced models of viral inflammation, cancer, and neurodegeneration. This guide details data-backed workflows, cutting-edge applications, and troubleshooting strategies to maximize reliability in ubiquitin-proteasome pathway research.

• Phalloidin (B7678): Technical Use Guide for F-Actin Stabiliz

  2026-06-08

  Phalloidin (B7678) is used for high-affinity stabilization and imaging of filamentous actin in fixed or permeabilized samples, providing robust cytoskeleton visualization for cell biology research. It is not suitable for live-cell studies or experiments requiring reversible actin binding. Researchers should apply it where static analysis of actin structure is required.

• ETS1 Regulates Mitophagy in BPD via SENP2/HSPA8/FUNDC1 Axis

  2026-06-08

  This study identifies ETS1 as a novel transcriptional regulator that mitigates bronchopulmonary dysplasia (BPD) by suppressing mitochondrial damage-induced mitophagy through the SENP2/HSPA8/FUNDC1 pathway. The findings provide mechanistic insights into chaperone-mediated autophagy in neonatal lung disease, offering new molecular targets for therapeutic intervention.

• Axitinib (AG 013736): Selective VEGFR Inhibitor for Cancer R

  2026-06-07

  Axitinib (AG 013736) is a highly selective, orally bioavailable inhibitor of VEGFR1, VEGFR2, and VEGFR3. It demonstrates nanomolar potency in angiogenesis inhibition assays and robust tumor growth suppression in xenograft models, supporting precision cancer biology research.

• G007-LK Tankyrase 1/2 Inhibitor: Precision Tool for Wnt Path

  2026-06-06

  G007-LK is a nanomolar tankyrase 1/2 inhibitor enabling robust Wnt/β-catenin pathway inhibition and β-catenin degradation, especially in APC-mutant colorectal cancer and hepatocellular carcinoma research. This article presents actionable protocols, advanced troubleshooting, and key insights translating bench discoveries into reproducible workflows.

• Verteporfin (CL 318952): Applied Workflows for PDT & Autopha

  2026-06-05

  Verteporfin (CL 318952) stands apart as a dual-action photosensitizer and autophagy inhibitor, offering robust performance in photodynamic therapy and advanced cell biology assays. This guide delivers protocol-driven insights and troubleshooting strategies for maximizing reproducibility and data quality with Verteporfin from APExBIO.

• Carvacrol: Redox Modulation and Precision in TRP Channel Res

  2026-06-05

  Explore Carvacrol’s unique role as a monoterpene phenol in TRP channel and redox biology research. This article offers a deep dive into mechanistic insights, advanced assay design, and the implications of recent breakthroughs for cell cycle and apoptosis studies.

16380 records 1/1092 page Next 12345 下5页 Last page